Your contact person
Manager PR & Communications Jan Phillip Denkers
Evotec and Sanofi in exclusive talks to create an Infectious Disease open innovation R&D platform
Evotec AG and Sanofi have entered into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform ...
Read more …
Macro instruments now usable for nearly all HF generators
Söring GmbH is now offering its Macro HF instruments with the international 3-pin connector. This makes it easy to connect them to almost any ...
Read more …
Nicole Elleuche to be new Managing and Administrative Director
The European XFEL Council, the highest governing organ of European XFEL, appointed Dr. Nicole Elleuche as European XFEL’s new administrative director. She will take ...
Read more …
Topas Therapeutics serves as exclusive translational partner for Collaborative Research Center focused on liver inflammation at University Medical Center Hamburg-Eppendor
Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the natural tolerance induction capabilities of the liver, today announced that it will ...
Read more …
MAGIA project kick-off meeting
The Kick-Off Meeting of the newly launched European Medtech Alliance dedicated to support SME Internationalisation was held in Colleretto Giacosa (Italy) on January 15-16th, ...
Read more …
Investment Plan for Europe: EIB grants loan of EUR 40m to Indivumed
The European Investment Bank (EIB) will provide a loan of EUR 40m to Indivumed GmbH, a physician-led, integrated global oncology company providing high-content tumour ...
Read more …
Evotec and APEIRON achieve first milestone in immuno-oncology alliance with Sanofi
Evotec AG and APEIRON Biologics AG, a company focused on cancer immunotherapy, announced today that the companies received the first milestone payment from Sanofi ...
Read more …
The Center for Applied Nanotechnology CAN to become new research division at the Fraunhofer IAP
The Center for Applied Nanotechnology (CAN) GmbH was integrated into the Fraunhofer Institute for Applied Polymer Research (Potsdam-Golm) on January 1, 2018. Under the ...
Read more …
Topas Therapeutics extends its Series A with Boehringer Ingelheim Venture Fund
Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the natural tolerance induction capabilities of the liver, today announced that the Boehringer ...
Read more …
Evotec joins forces with academic leaders to accelerate drug discovery in kidney diseases and build "NEPLEX"
Evotec AG today announced a strategic collaboration on microfluidics technology including induced pluripotent stem cell ("iPSC") differentiation with leading academic institutions in the UK ...
Read more …
Topas Therapeutics extends its Series A to EUR 18 Million (USD 21 Million) with Boehringer Ingelheim Venture Fund
Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company leveraging the natural tolerance induction capabilities of the liver, today announced that the Boehringer ...
Read more …
Crystals in a pink X-ray beam
A newly developed experimental set-up allows the X-ray structure determination of biomolecules such as proteins with far smaller samples and shorter exposure times than ...
Read more …